MKLY: McKinley Acquisition reports $422,668 net income for the quarter

McKinley Acquisition (MKLY), a SPAC, reported Q3 net income of $422,668, driven by $1.63M trust interest income and offset by $1.16M G&A costs. The company has no operating revenue and is pending a Space-Eyes business combination.

Original reporting
Published Nov 13, 2026, 10:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 11:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MKLY
Neutral
high confidence
Mentioned
$MKLY
Relevance
4/10
AlphAI data visualization · based on quantisnow.com
Decision brief

The 30-second read

$MKLYNeutralLow
01

Why it matters

The disclosed net income is modest and does not change the fundamental outlook; investors will focus on the pending merger rather than quarterly earnings.

02

Market read

Limited relevance; the filing provides a small profit figure but no operational progress.

03

What to watch

Potential future upside depends on the upcoming Space‑Eyes merger, which is not reflected in current earnings.

Relevance 4/10Novelty 2/10Timing: post‑filing disclosure

Background

MKLY is a Nasdaq‑listed SPAC awaiting a business combination with Space‑Eyes. The filing reports its only income source—interest on trust assets.

Company-level read

Ticker impact

$MKLYNeutralHigh confidence
Context

MKLY disclosed Q3 net income of $422,668, derived mainly from trust account interest, with no operating revenue.

Expected impact

likely limited pressure as investors weigh lack of operating revenue against small net income.

Evidence & confidence

The numbers are small and the SPAC has no revenue, so the market impact is expected to be minimal.

Market effects

None significant for the broader blank‑check or space sector.

No regional effect; the filing is specific to MKLY.

Low; the SPAC's modest earnings do not influence global markets.

Counterpoint

If investors anticipate a high‑value business combination, the trust interest profit could be seen as a positive cash cushion.

Key entities

  • McKinley Acquisition Corporation

    Nasdaq‑listed SPAC (ticker MKLY) reporting Q3 results.

  • Space‑Eyes

    Proposed merger partner for MKLY.

Related articles

$SBCHigh

Why SBC Medical Stock Skyrocketed on Friday

SBC Medical Group (NASDAQ:SBC) shares rose 37% after reporting Q3 revenue of $59M, up 35% YoY, and announcing an AI partnership with NeuroBrain Dynamics. The company added 36 clinics, increasing total locations to 293, and saw a 9% rise in patient visits. Operating income surged 66% to $26M, with a 45% operating margin.

$BTOMedAI 8/10

B2Gold Earnings Call Signals Lower Costs and Growth

B2Gold Corp. reported Q3 earnings with strong production, lower cost guidance, and positive free cash flow. The company produced 193,000 ounces of gold, reduced all-in sustaining cost guidance by over $100 per ounce, and generated $48 million in free cash flow. Revenue reached $836 million, supported by higher gold prices. The company also highlighted growth projects and shareholder returns.

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.